These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 28562302)

  • 1. Trends in Patent Ductus Arteriosus Diagnosis and Management for Very Low Birth Weight Infants.
    Ngo S; Profit J; Gould JB; Lee HC
    Pediatrics; 2017 Apr; 139(4):. PubMed ID: 28562302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation and comparative effectiveness of patent ductus arteriosus pharmacotherapy in extremely low birth weight infants.
    ElHassan NO; Bird TM; King AJ; Ambadwar PB; Jaquiss RD; Kaiser JR; Robbins JM
    J Neonatal Perinatal Med; 2014 Jan; 7(3):229-35. PubMed ID: 25322995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital variation in medical and surgical treatment of patent ductus arteriosus.
    Lee HC; Durand DJ; Danielsen B; Dueñas GV; Powers RJ
    Am J Perinatol; 2015 Mar; 32(4):379-86. PubMed ID: 25241108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends and variation in management and outcomes of very low-birth-weight infants with patent ductus arteriosus.
    Hagadorn JI; Brownell EA; Trzaski JM; Johnson KR; Lainwala S; Campbell BT; Herbst KW
    Pediatr Res; 2016 Dec; 80(6):785-792. PubMed ID: 27509008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What happens when the patent ductus arteriosus is treated less aggressively in very low birth weight infants?
    Kaempf JW; Wu YX; Kaempf AJ; Kaempf AM; Wang L; Grunkemeier G
    J Perinatol; 2012 May; 32(5):344-8. PubMed ID: 21818064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the Diagnosis and Management of Patent Ductus Arteriosus from 2006 to 2015 in United States Neonatal Intensive Care Units.
    Bixler GM; Powers GC; Clark RH; Walker MW; Tolia VN
    J Pediatr; 2017 Oct; 189():105-112. PubMed ID: 28600155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombocytopenia in the first 24 hours after birth and incidence of patent ductus arteriosus.
    Sallmon H; Weber SC; Hüning B; Stein A; Horn PA; Metze BC; Dame C; Bührer C; Felderhoff-Müser U; Hansmann G; Koehne P
    Pediatrics; 2012 Sep; 130(3):e623-30. PubMed ID: 22869835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of pharmacologic closure of patent ductus arteriosus in small-for-gestational-age extremely preterm infants.
    Boghossian NS; Do BT; Bell EF; Dagle JM; Brumbaugh JE; Stoll BJ; Vohr BR; Das A; Shankaran S; Sanchez PJ; Wyckoff MH; Bethany Ball M;
    Early Hum Dev; 2017 Oct; 113():10-17. PubMed ID: 28697406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A conservative treatment of patent ductus arteriosus in very low birth weight infants.
    Letshwiti JB; Semberova J; Pichova K; Dempsey EM; Franklin OM; Miletin J
    Early Hum Dev; 2017 Jan; 104():45-49. PubMed ID: 28042972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.
    Van Overmeire B; Smets K; Lecoutere D; Van de Broek H; Weyler J; Degroote K; Langhendries JP
    N Engl J Med; 2000 Sep; 343(10):674-81. PubMed ID: 10974130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Patent Ductus Arteriosus with Cyclo-oxygenase Inhibitors beyond 2 Weeks of Age in Very Low Birth Weight Infants.
    Lainwala S; Hussain N
    Am J Perinatol; 2016 May; 33(6):584-9. PubMed ID: 26731181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Mortality and In-Hospital Outcomes of Preterm Infants Treated with Ibuprofen for Patent Ductus Arteriosus with or without Clinical Symptoms Attributable to the Patent Ductus Arteriosus at the Time of Ibuprofen Treatment.
    Yoo H; Lee JA; Oh S; Jung YH; Sohn JA; Shin SH; Choi CW; Kim EK; Kim HS; Kim BI
    J Korean Med Sci; 2017 Jan; 32(1):115-123. PubMed ID: 27914140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of patent ductus arteriosus: indomethacin or ibuprofen?
    Linder N; Bello R; Hernandez A; Rosen C; Birk E; Sirota L; Pushkov Y; Klinger G
    Am J Perinatol; 2010 May; 27(5):399-404. PubMed ID: 20013578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infants.
    Adrouche-Amrani L; Green RS; Gluck KM; Lin J
    BMC Pediatr; 2012 Jan; 12():10. PubMed ID: 22284694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung function in very low birth weight infants after pharmacological and surgical treatment of patent ductus arteriosus - a retrospective analysis.
    Barikbin P; Sallmon H; Wilitzki S; Photiadis J; Bührer C; Koehne P; Schmalisch G
    BMC Pediatr; 2017 Jan; 17(1):5. PubMed ID: 28056907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early or late surgical ligation of medical refractory patent ductus arteriosus in premature infants.
    Hsiao CC; Wung JT; Tsao LY; Chang WC
    J Formos Med Assoc; 2009 Jan; 108(1):72-7. PubMed ID: 19181611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of outcome in 298 extremely low-birth-weight infants with patent ductus arteriosus.
    Alexander F; Chiu L; Kroh M; Hammel J; Moore J
    J Pediatr Surg; 2009 Jan; 44(1):112-7; disscusion 117. PubMed ID: 19159727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus.
    Gulack BC; Laughon MM; Clark RH; Sankar MN; Hornik CP; Smith PB
    Early Hum Dev; 2015 Dec; 91(12):725-9. PubMed ID: 26386610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patent ductus arteriosus management and outcomes in Japan and Canada: comparison of proactive and selective approaches.
    Isayama T; Mirea L; Mori R; Kusuda S; Fujimura M; Lee SK; Shah PS;
    Am J Perinatol; 2015 Sep; 32(11):1087-94. PubMed ID: 25825965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PATENT DUCTUS ARTERIOSUS CLOSURE: EXPERIENCE FROM A TERTIARY REFERRAL CENTER.
    Faim DRO; Tiago JAM; Castelo RJS; Francisco ASS; Alves RR; Pires AMGS
    Rev Paul Pediatr; 2020; 39():e2020013. PubMed ID: 33263696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.